Markus Brielmeier Selected Research

Markus Brielmeier Research Topics

2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 07/2015 - 12/2011
1	Atherosclerosis 01/2021
1	Body Weight (Weight, Body) 01/2021
1	Inflammation (Inflammations) 01/2021
1	Obesity 01/2021
1	Metabolic Diseases (Metabolic Disease) 01/2021
1	Non-alcoholic Fatty Liver Disease 01/2021
1	Perinatal Death 07/2015
1	Atrophy 05/2014
1	Ischemia 12/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2011
1	Hypoxia (Hypoxemia) 12/2011
1	Reperfusion Injury 12/2011
1	Neurodegenerative Diseases (Neurodegenerative Disease) 03/2008
1	Carcinoma (Carcinomatosis) 09/2007
1	Neoplasms (Cancer) 09/2007
1	Adenocarcinoma 09/2007
1	Carcinogenesis 09/2007

2	Thioredoxin Reductase 2IBA 07/2015 - 12/2011
2	Thioredoxin-Disulfide ReductaseIBA 12/2011 - 03/2008
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Blood Proteins (Serum Proteins)IBA 01/2021
1	Phosphates (Orthophosphate)IBA 01/2021
1	Glucose (Dextrose)FDA LinkGeneric 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2021
1	6-propylchromone-2-carboxylic acid (PCCA)IBA 05/2014
1	selenium transferaseIBA 05/2014
1	Selenoproteins (Selenoprotein)IBA 05/2014
1	Tamoxifen FDA LinkGeneric 12/2011
1	Acetylcysteine (Siran)FDA LinkGeneric 12/2011
1	Mitochondrial Permeability Transition PoreIBA 12/2011
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2011
1	ThioredoxinsIBA 03/2008
1	Oxidoreductases (Dehydrogenase)IBA 03/2008
1	Transforming Growth Factor alpha (TGF-alpha)IBA 09/2007
1	SeleniumIBA 09/2007
1	Trace Elements (Biometals)IBA 09/2007